Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identifying Protein Features Responsible for Improved Drug Repurposing Accuracies Using the CANDO Platform: Implications for Drug Design
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 1, Pages 167
Publisher
MDPI AG
Online
2019-01-05
DOI
10.3390/molecules24010167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal
- (2017) Preeti Pandey et al. FEBS LETTERS
- Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library
- (2017) Hongxia Niu et al. Emerging Microbes & Infections
- Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform
- (2016) Gaurav Chopra et al. CURRENT PHARMACEUTICAL DESIGN
- Combating Ebola with Repurposed Therapeutics Using the CANDO Platform
- (2016) Gaurav Chopra et al. MOLECULES
- Predicting the Future — Big Data, Machine Learning, and Clinical Medicine
- (2016) Ziad Obermeyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
- (2016) Harri M. Itkonen et al. Oncotarget
- Toward Repurposing Metformin as a Precision Anti-Cancer Therapy Using Structural Systems Pharmacology
- (2016) Thomas Hart et al. Scientific Reports
- Role of computer-aided drug design in modern drug discovery
- (2015) Stephani Joy Y. Macalino et al. ARCHIVES OF PHARMACAL RESEARCH
- Relating Essential Proteins to Drug Side-Effects Using Canonical Component Analysis: A Structure-Based Approach
- (2015) Tianyun Liu et al. Journal of Chemical Information and Modeling
- Multiscale Modelling of Relationships between Protein Classes and Drug Behavior Across all Diseases Using the CANDO Platform
- (2015) Geetika Sethi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Machine learning applications in cancer prognosis and prediction
- (2015) Konstantina Kourou et al. Computational and Structural Biotechnology Journal
- CANDO and the infinite drug discovery frontier
- (2014) Mark Minie et al. DRUG DISCOVERY TODAY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine
- (2014) Rajnish Sahu et al. MALARIA JOURNAL
- Inferring protein domains associated with drug side effects based on drug-target interaction network
- (2013) Hiroaki Iwata et al. BMC Systems Biology
- Computational Drug Repositioning: From Data to Therapeutics
- (2013) M R Hurle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery
- (2013) X. Liu et al. CURRENT MEDICINAL CHEMISTRY
- Polypharmacology in a Single Drug: Multitarget Drugs
- (2013) M. L. Bolognesi CURRENT MEDICINAL CHEMISTRY
- Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites
- (2013) Laura M. Alcantara et al. EXPERIMENTAL PARASITOLOGY
- Phase II and Phase III attrition rates 2011–2012
- (2013) John Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
- (2013) Michael P. Menden et al. PLoS One
- KoBaMIN: a knowledge-based minimization web server for protein structure refinement
- (2012) J. P. G. L. M. Rodrigues et al. NUCLEIC ACIDS RESEARCH
- The Comparative Toxicogenomics Database: update 2013
- (2012) Allan Peter Davis et al. NUCLEIC ACIDS RESEARCH
- COFACTOR: an accurate comparative algorithm for structure-based protein function annotation
- (2012) Ambrish Roy et al. NUCLEIC ACIDS RESEARCH
- Computational tools for polypharmacology and repurposing
- (2011) Janosch Achenbach et al. Future Medicinal Chemistry
- HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment
- (2011) Michael Remmert et al. NATURE METHODS
- Antimalarial Activity of Potential Inhibitors of Plasmodium falciparum Lactate Dehydrogenase Enzyme Selected by Docking Studies
- (2011) Julia Penna-Coutinho et al. PLoS One
- Automated protein structure modeling in CASP9 by I-TASSER pipeline combined with QUARK-based ab initio folding and FG-MD-based structure refinement
- (2011) Dong Xu et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
- (2011) R. Huang et al. Science Translational Medicine
- Open Babel: An open chemical toolbox
- (2011) Noel M O'Boyle et al. Journal of Cheminformatics
- PubChem as a public resource for drug discovery
- (2010) Qingliang Li et al. DRUG DISCOVERY TODAY
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
- (2010) C. Knox et al. NUCLEIC ACIDS RESEARCH
- Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory Peptides
- (2010) Joshua M. Costin et al. PLoS Neglected Tropical Diseases
- Antimalarial Activity of Tigecycline, a Novel Glycylcycline Antibiotic
- (2009) P. Starzengruber et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Properties and identification of human protein drug targets
- (2009) Tala M. Bakheet et al. BIOINFORMATICS
- I-TASSER server for protein 3D structure prediction
- (2008) Yang Zhang BMC BIOINFORMATICS
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Novel paradigms for drug discovery: computational multitarget screening
- (2008) E JENWITHEESUK et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started